Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNA3103 (LGR5-targeted CAR-T) in metastatic colorectal cancer
NCT05759728Phase 2Recruiting
- Sponsor
- Carina Biotech
- Start
- Oct 2023
- Primary completion
- Dec 2027
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CNA3103 in colorectal cancer (CRC), sponsored by Carina Biotech. Started Oct 2023; status: recruiting.
02
Drugs
CNA3103
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05759728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05759728.